Ron Freedman, Publisher,
on behalf of
Jeffrey Crelinsten, Publisher
Mark Henderson, Managing Editor
Annlee Chad, Editorial
Vaughn Gillson, Subscriptions
Andrew St. Denis, Web Manager
This issue of RE$EARCH MONEY is the last we will publish in calendar year 2000. And what a year it has been. It all began with word that the parent firm of RE$EARCH MONEY was in bankruptcy and the newsletter had ceased publication.
CIHR seeking firm funding commitment as momentum builds at Canada's premier health research funding agency
After just six months of operation, the structure and direction of the Canadian Institutes of Health Research (CIHR) has taken a giant leap forward with the appointment of 13 scientific directors (SDs) to head up its fledgling Institutes.
Canada must develop a national genomics strategy and dramatically increase its investment in the field to ensure a place in the post-human genome world of proteomics, sequencing and functional genomics.
Ottawa's life sciences sector following growth pattern similar to region's successful high-technology sector
The architects of Ottawa’s diverse life sciences sector will be closely monitoring the success of the regions booming high-technology cluster as it positions itself for future growth. Ranked third or fourth by size in Canada after Toronto, Montreal and possibly Vancouver, the life sciences sector has been successful in attracting significant projects to the area, largely on the strength of its public research base.
eMPOWR campaign to increase pipeline of personnel for key technology sectors gets boost with release of two surveys
The eMPOWR Canada campaign to stimulate the pipeline of graduates in strategic communications technologies sectors has beefed up its case for nearly $500 million in new federal funding, with the release of a double survey on industry and university needs.
A report commissioned by the Information Technology Association of Canada (ITAC), IBM Canada Ltd and Microsoft Canada shows that investment in information technology (IT) is having a significant positive impact on Canada’s output growth and labour productivity.
Caprion Pharmaceuticals Inc has made Canadian biotechnology history, attracting the largest private placement to date with a $52.5-million investment by venture capital and institutional investors. The Montreal-based proteomics company has now raised $64 million in capital and will use the funds to conduct research for diagnostic compounds and therapeutics products combining sub-cellular biology and large-scale mass spectrometry.
Primaxis Technology Ventures Inc has finally reached and surpassed its goal of establishing a $50-million seed capital fund to exploit emerging discoveries in the telecommunications, semiconductor and electronics, advanced materials and manufacturing and information technology infrastructure sectors.